HK1043315A1 - Triazineone compounds for treating diseases due tosarcosystis, neospora and toxoplasma. - Google Patents

Triazineone compounds for treating diseases due tosarcosystis, neospora and toxoplasma.

Info

Publication number
HK1043315A1
HK1043315A1 HK02105016A HK02105016A HK1043315A1 HK 1043315 A1 HK1043315 A1 HK 1043315A1 HK 02105016 A HK02105016 A HK 02105016A HK 02105016 A HK02105016 A HK 02105016A HK 1043315 A1 HK1043315 A1 HK 1043315A1
Authority
HK
Hong Kong
Prior art keywords
neospora
toxoplasma
diseases due
tosarcosystis
treating diseases
Prior art date
Application number
HK02105016A
Other languages
English (en)
Inventor
Thomas J Kennedy
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HK1043315A1 publication Critical patent/HK1043315A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK02105016A 1998-12-22 2002-07-04 Triazineone compounds for treating diseases due tosarcosystis, neospora and toxoplasma. HK1043315A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/218,713 US6194408B1 (en) 1998-12-22 1998-12-22 Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma
PCT/US1999/030293 WO2000037064A2 (en) 1998-12-22 1999-12-18 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma

Publications (1)

Publication Number Publication Date
HK1043315A1 true HK1043315A1 (en) 2002-09-13

Family

ID=22816196

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105016A HK1043315A1 (en) 1998-12-22 2002-07-04 Triazineone compounds for treating diseases due tosarcosystis, neospora and toxoplasma.

Country Status (17)

Country Link
US (1) US6194408B1 (xx)
EP (1) EP1140102B1 (xx)
JP (1) JP4806121B2 (xx)
KR (1) KR100661102B1 (xx)
CN (1) CN1188128C (xx)
AT (1) ATE270891T1 (xx)
AU (1) AU770108B2 (xx)
BR (1) BR9916432A (xx)
CA (1) CA2356151C (xx)
DE (1) DE69918716T2 (xx)
ES (1) ES2226492T3 (xx)
HK (1) HK1043315A1 (xx)
HU (1) HU228994B1 (xx)
NZ (1) NZ512478A (xx)
PT (1) PT1140102E (xx)
WO (1) WO2000037064A2 (xx)
ZA (1) ZA200104205B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6469987B1 (en) 1998-01-13 2002-10-22 Enterasys Networks, Inc. Virtual local area network with trunk stations
BR9914385A (pt) 1998-10-08 2001-07-17 New Ace Res Company Composição útil para o tratamento e prevenção de infecções protozoárias no homem e em animais, e, método de tratamento de uma infecção protozoária no homem e em animais
DE19958388A1 (de) * 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
CA2407517A1 (en) * 2000-04-25 2001-11-01 Wyeth Equine protozoal myeloencephalitis vaccine
DE10040110A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen
US6562007B1 (en) * 2000-09-28 2003-05-13 Bayer Healthcare Llc Adjustable dosage syringe
DE602004009664D1 (de) * 2003-01-16 2007-12-06 Janssen Pharmaceutica Nv Diclazurilhaltige antiprotozoenmittel
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
DE102009012423A1 (de) * 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
KR101148098B1 (ko) * 2010-04-30 2012-05-22 한국화학연구원 1-［4-（4-니트로-페녹시）-페닐］-프로판-1-온을 유효성분으로 함유하는 톡소포자충 및 콕시디움에 기인한 질환의 예방 및 치료용 조성물
KR101242535B1 (ko) * 2010-10-05 2013-03-12 주식회사이-글벳 콕시듐 치료 및 예방을 위한 조성물의 제조방법
CN102772363B (zh) * 2012-08-22 2013-10-09 青岛康地恩药业股份有限公司 一种含泊那珠利的溶液剂及其制备方法
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
US20220000876A1 (en) * 2018-11-02 2022-01-06 Adamis Pharmaceuticals Corporation Drug compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2313721A1 (de) * 1973-03-20 1974-10-03 Bayer Ag Neue 1-phenylsubstituierte 1,3,5triazine, verfahren zu ihrer herstellung, sowie ihre verwendung als arzneimittel
AU616916B2 (en) 1987-11-20 1991-11-14 Kissei Pharmaceutical Co. Ltd. 4h-quinolizin-4-one compounds exhibiting therapeutic activities
DE3826058A1 (de) 1988-07-30 1990-02-08 Bayer Ag Mittel gegen fischparasiten
US4933341A (en) * 1988-10-08 1990-06-12 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
US5196562A (en) 1988-10-08 1993-03-23 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
EP0377903A3 (de) 1989-01-09 1991-07-17 Bayer Ag Substituierte Hexahydro-1,2,4-triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
CN1044905A (zh) 1989-02-16 1990-08-29 赫彻斯特股份公司 鱼和昆虫寄生虫对抗剂
DE4030042A1 (de) 1990-05-17 1991-11-21 Bayer Ag Verwendung von substituierten 1,2,4-triazindionen
DE4120138A1 (de) 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
WO1998043644A1 (en) * 1997-03-31 1998-10-08 David Granstrom Formulations and methods to treat and prevent equine protozoal myeloencephalitis
US5883095A (en) * 1997-08-07 1999-03-16 University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
US5830893A (en) * 1997-04-23 1998-11-03 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoan myeloencephalitis using triazinediones

Also Published As

Publication number Publication date
ATE270891T1 (de) 2004-07-15
CA2356151A1 (en) 2000-06-29
CN1188128C (zh) 2005-02-09
CN1331594A (zh) 2002-01-16
AU770108B2 (en) 2004-02-12
NZ512478A (en) 2003-07-25
DE69918716D1 (de) 2004-08-19
HU228994B1 (en) 2013-07-29
BR9916432A (pt) 2001-09-04
DE69918716T2 (de) 2005-08-04
EP1140102B1 (en) 2004-07-14
KR20010087412A (ko) 2001-09-15
JP2002532545A (ja) 2002-10-02
ES2226492T3 (es) 2005-03-16
WO2000037064A3 (en) 2000-10-26
AU2370900A (en) 2000-07-12
ZA200104205B (en) 2002-05-22
KR100661102B1 (ko) 2006-12-26
EP1140102A2 (en) 2001-10-10
WO2000037064A2 (en) 2000-06-29
US6194408B1 (en) 2001-02-27
HUP0104710A3 (en) 2003-10-28
HUP0104710A2 (hu) 2002-04-29
JP4806121B2 (ja) 2011-11-02
PT1140102E (pt) 2004-10-29
CA2356151C (en) 2009-02-24

Similar Documents

Publication Publication Date Title
HK1043315A1 (en) Triazineone compounds for treating diseases due tosarcosystis, neospora and toxoplasma.
LU91254I2 (fr) Daptomycine et ses dérivés pharmaceutiquement acceptables (cubicinr)
MY119375A (en) Treatment of tinnitus using neuroprotective agents
GB0130677D0 (en) Medicaments and novel compounds
HK1045266A1 (en) Triazineone compounds for treating diseases due tosarcosystis, neospora and toxoplasma
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
HK1024424A1 (en) Methods of therapeutic administration of anti-cd40l compounds
BR9916417A (pt) Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasma
BR0110396A (pt) Métodos para prevenir e tratar alopecia induzida por quimioterapia ou radioterapia
PT986393E (pt) Utilizacao de um nitroxido ou de um seu pro-farmaco no tratamento profilactico e terapeutico do cancro
EP1056458A4 (en) METHODS FOR TREATING PAIN, INCLUDING CHRONIC AND WOMAN-SPECIFIC PAIN
HK1059894A1 (en) Praziquantel compounds for treating diseases due to sarcocystis, neospora, toxoplasma and isospora
MXPA01007952A (es) Formulaciones a base de l-arginina para tratar enfermedades, y metodos para usarlas.
ATE248607T1 (de) Aminotetralin derivate zur therapie der kardiovaskulären erkrankungen
EA200200846A1 (ru) Соединения, полезные для лечения или предупреждения заболеваний, опосредуемых альфа-2в-адреноцептором
UA33498A (uk) Спосіб лікування терапевтично резистентних форм шизофренії

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20191217